Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells

Virginia Spano', Maria Valeria Raimondi, Alessandra Montalbano, Paola Barraja, Marilia Barreca, Ernest Hamel, Francesco Bertoni, Gaudio, Bai, Alcaro

Research output: Contribution to conferencePosterpeer-review


Anti-tubulin agents are important chemotherapeutics.Combretastatin A-4 (CA-4) emerged as lead compound for the design ofnew tubulin-binding agents. Its analogues 4,5-diarylisoxazoles, containingthe [1,2]oxazole ring as linker of two aryl moieties, displayed higher antitubulinactivity than CA-4. [1,2]oxazolo[5,4-e]isoindoles also gave excellentresults reducing cell growth of NCI-60 tumor cell lines and diffuse malignantperitoneal mesothelioma (DMPM) cells. Selected derivatives showed in vivoantitumor activity at well-tolerated doses in a DMPM xenograft model.[1,2]oxazolo[5,4-e]isoindoles were screened in four lymphoma histotypes:germinal center B-cell and activated diffuse large B cell lymphoma, marginalzone lymphoma and mantle cell lymphoma.
Original languageEnglish
Number of pages2
Publication statusPublished - 2020

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research


Dive into the research topics of 'Evaluation of [1,2]oxazolo[5,4-e]isoindoles in lymphoma cells'. Together they form a unique fingerprint.

Cite this